Clinical Trial

A Real World Study of Sacituzumab Govitecan

Name: A Real World Study of Sacituzumab Govitecan — clinical trial record (NCT06966141)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated May 11, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

Clinical Outcomes and Safety of Sacituzumab Govitecan in Metastatic HER-2 negative Breast Cancer Patients

Trial Details

NCT Number	NCT06966141
Lead Sponsor	Fudan University
Conditions	Breast Cancer Metastatic, Treatment Outcome
Enrollment	100 participants
Start Date	2024-08-12
Primary Completion	2026-08-01 (estimated)
Study Completion	2027-08-01 (estimated)
Updated on ClinicalTrials.gov	2025-05-11